AMDV Vaccine: Challenges and Perspectives

Viruses. 2021 Sep 14;13(9):1833. doi: 10.3390/v13091833.

Abstract

Aleutian mink disease virus (AMDV) is known to cause the most significant disease in the mink industry. It is globally widespread and manifested as a deadly plasmacytosis and hyperglobulinemia. So far, measures to control the viral spread have been limited to manual serological testing for AMDV-positive mink. Further, due to the persistent nature of this virus, attempts to eradicate Aleutian disease (AD) have largely failed. Therefore, effective strategies to control the viral spread are of crucial importance for wildlife protection. One potentially key tool in the fight against this disease is by the immunization of mink against AMDV. Throughout many years, several researchers have tried to develop AMDV vaccines and demonstrated varying degrees of protection in mink by those vaccines. Despite these attempts, there are currently no vaccines available against AMDV, allowing the continuation of the spread of Aleutian disease. Herein, we summarize previous AMDV immunization attempts in mink as well as other preventative measures with the purpose to shed light on future studies designing such a potentially crucial preventative tool against Aleutian disease.

Keywords: AMDV; Aleutian disease; Aleutian mink disease virus; mink parvovirus; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aleutian Mink Disease / immunology
  • Aleutian Mink Disease / prevention & control*
  • Aleutian Mink Disease Virus / immunology*
  • Animals
  • Drug Design
  • Mink* / immunology
  • Vaccine Development*
  • Vaccines, DNA / immunology
  • Vaccines, Subunit / immunology
  • Viral Vaccines / immunology*

Substances

  • Vaccines, DNA
  • Vaccines, Subunit
  • Viral Vaccines